ArticleBiology2023

Iguratimod Ameliorates the Severity of Secondary Progressive Multiple Sclerosis in Model Mice by Directly Inhibiting IL-6 Production and Th17 Cell Migration via Mitigation of Glial Inflammation.

Satoshi Nagata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.